Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma

1 Jan 2023

Abstract excerpt

Background: Clear-cell renal cell carcinoma (ccRCC) is the most common malignant kidney cancer. However, the tumor microenvironment and crosstalk involved in metabolic reprogramming in ccRCC are not well-understood. Methods: We used The Cancer Genome Atlas to obtain ccRCC transcriptome data and clinical information. The E-MTAB-1980 cohort was used for external validation. The GENECARDS database contains the first...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Ferroptosis and cancer prognosis
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37304236
DOI: 10.32604/or.2023.028051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinomaPMID 37304236Read ↗

Identification of a Combined Immune- and Metabolism- Related Prognostic Signature for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Comprehensive analysis of LD-related genes signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinomaSemantic proximity Read ↗

Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinomaSemantic proximity Read ↗

Clinical value and in vitro validation of gene and molecular subtype identification in renal clear cell carcinomaSemantic proximity Read ↗

A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.Semantic proximity Read ↗

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinomaSemantic proximity Read ↗

Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits.Semantic proximity Read ↗

Establishment of a Seven-Gene Signature Associated with CD8+ T Cells through the Utilization of Both Single-Cell and Bulk RNA-Sequencing Techniques in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Identification of G protein-coupled receptor gene and immune infiltration analysis to construct a prognostic model for renal clear cell carcinoma patientsSemantic proximity Read ↗

Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinomaSemantic proximity Read ↗

Machine Learning-Driven Prognostic Analysis of Cuproptosis and Disulfidptosis-related lncRNAs in Clear Cell Renal Cell Carcinoma: A Step Towards Precision OncologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.